These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197 [TBL] [Abstract][Full Text] [Related]
3. Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611 [No Abstract] [Full Text] [Related]
4. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205 [TBL] [Abstract][Full Text] [Related]
6. Low penetrance breast cancer predisposition SNPs are site specific. Mcinerney N; Colleran G; Rowan A; Walther A; Barclay E; Spain S; Jones AM; Tuohy S; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E Breast Cancer Res Treat; 2009 Sep; 117(1):151-9. PubMed ID: 19005751 [TBL] [Abstract][Full Text] [Related]
7. Sex steroid hormone metabolism and prostate cancer. Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991 [TBL] [Abstract][Full Text] [Related]
8. The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability. Ganguly S; Naik D; Muskara A; Mian OY Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33260197 [TBL] [Abstract][Full Text] [Related]
9. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386 [TBL] [Abstract][Full Text] [Related]
10. A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers. Creighton CJ BMC Genomics; 2007 Jun; 8():199. PubMed ID: 17598908 [TBL] [Abstract][Full Text] [Related]
11. Perspective: prostate cancer susceptibility genes. Simard J; Dumont M; Soucy P; Labrie F Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166 [TBL] [Abstract][Full Text] [Related]
12. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. Platz EA; Giovannucci E J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987 [TBL] [Abstract][Full Text] [Related]
13. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner. Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168 [TBL] [Abstract][Full Text] [Related]
14. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer. Rosa-Rosa JM; Pita G; González-Neira A; Milne RL; Fernandez V; Ruivenkamp C; van Asperen CJ; Devilee P; Benitez J Breast Cancer Res Treat; 2009 Nov; 118(1):151-9. PubMed ID: 19205878 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617 [TBL] [Abstract][Full Text] [Related]
16. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. Das S; Yeung KT; Mahajan MA; Samuels HH BMC Cancer; 2014 Nov; 14():852. PubMed ID: 25409762 [TBL] [Abstract][Full Text] [Related]
17. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Osorio A; Rodríguez-López R; Díez O; de la Hoya M; Ignacio Martínez J; Vega A; Esteban-Cardeñosa E; Alonso C; Caldés T; Benítez J Int J Cancer; 2004 Jan; 108(1):54-6. PubMed ID: 14618615 [TBL] [Abstract][Full Text] [Related]
18. ["Prostatic" kallikreins, sex hormones and insulin-like growth factors: complex of male and female regulatory elements in health and carcinogenesis]. Zezerov EG; Severin ES Vestn Ross Akad Med Nauk; 1999; (3):49-56. PubMed ID: 10222833 [TBL] [Abstract][Full Text] [Related]
19. Targeting rapid action of sex steroid receptors in breast and prostate cancers. Giovannelli P; Di Donato M; Giraldi T; Migliaccio A; Castoria G; Auricchio F Front Biosci (Landmark Ed); 2011 Jun; 16(6):2224-32. PubMed ID: 21622172 [TBL] [Abstract][Full Text] [Related]
20. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]